TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Bio Forte AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,251
|
1,341
|
1,479 |
| Financial expenses |
1
|
1
|
1 |
| Earnings before taxes |
44
|
38
|
94 |
| Total assets |
413
|
410
|
408 |
| Current assets |
384
|
361
|
384 |
| Current liabilities |
114
|
126
|
139 |
| Equity capital |
299
|
283
|
268 |
| - share capital |
18
|
19
|
20 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
72.4%
|
69.0%
|
65.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
3.5%
|
2.8%
|
6.4% |
| Return on assets (ROA) |
10.9%
|
9.5%
|
23.3% |
| Current ratio |
336.8%
|
286.5%
|
276.3% |
| Return on equity (ROE) |
14.7%
|
13.4%
|
35.1% |
| Change turnover |
-5
|
-61
|
-167 |
| Change turnover % |
0%
|
-4%
|
-10% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.